Seres Therapeutics Set for Breakout on Impending Clinical Results
AI Prediction of Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, with its innovative microbiome therapeutic platform, presents a compelling investment opportunity, especially with upcoming clinical trial results expected to be a major catalyst. The company's focus on treating dysbiosis in the colonic microbiome could potentially redefine treatment paradigms across several gastrointestinal disorders.
MCRB Report Information
Prediction Date2025-07-03
Close @ Prediction$11.87
Mkt Cap83m
IPO DateN/a
AI-derived Information
Recent News for MCRB
- Apr 9, 7:00 am — Seres Therapeutics to Present at CARB-X Investor Day (GlobeNewswire)
- Mar 12, 7:23 am — Seres Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
- Mar 12, 7:00 am — Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates (GlobeNewswire)
- Mar 2, 4:05 pm — Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates (GlobeNewswire)
- Feb 12, 8:29 am — Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash (Benzinga)
- Feb 12, 7:00 am — Seres to lay off staff, pause top program in latest reboot (BioPharma Dive)
- Feb 12, 7:00 am — Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases (GlobeNewswire)
- Jan 6, 7:00 am — Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy (GlobeNewswire)
- Dec 29, 10:15 am — 3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround (Zacks)
- Nov 24, 7:00 am — Seres Therapeutics to Participate in Piper Sandler Healthcare Conference (GlobeNewswire)
- Nov 5, 7:00 am — Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
- Oct 30, 7:00 am — Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025 (GlobeNewswire)
NDAPR (News-Driven AI Prediction Revision) events for MCRB
No NDAPR events found.
Welcome to ScanScor. What you're reading is no ordinary summary -- it's the result of a carefully-crafted interactive session with OpenAI's most advanced models crafted from news, trial details, and financial data. This report attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers and to predict the future.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.